Fund Details
Overview
Investment portfolio
11rounds
| NAME | DATE | SIZE | |
|---|---|---|---|
Dandelion Health | May 2026Led | $14 MSeries A | |
Photon Health | Apr 2026Led | $16 MSeries A | |
Qualified Health | Mar 2026Participated | $125 MSeries B | |
Zarminali Health | Jan 2026Led | $110 MSeries A | |
Amae Health | Nov 2025Participated | $25 MSeries B | |
Hyro | Oct 2025Led | $45 MOther Equity | |
Daymark Health | Sep 2025Led | $20 MSeries A | |
Qualified Health | Jan 2025Participated | $30 MSeed | |
Medeloop | Nov 2024Participated | $16 MSeries A | |
Amae Health | May 2024Participated | $15 MSeries A | |
Ezra AI | Feb 2024Led | $21 MOther Equity | |
Dandelion Health | May 2026Led | $14 MSeries A | |
Photon Health | Apr 2026Led | $16 MSeries A | |
Qualified Health | Mar 2026Participated | $125 MSeries B | |
Zarminali Health | Jan 2026Led | $110 MSeries A | |
Amae Health | Nov 2025Participated | $25 MSeries B | |
Hyro | Oct 2025Led | $45 MOther Equity | |
Daymark Health | Sep 2025Led | $20 MSeries A | |
Qualified Health | Jan 2025Participated | $30 MSeed | |
Medeloop | Nov 2024Participated | $16 MSeries A | |
Amae Health | May 2024Participated | $15 MSeries A | |
Ezra AI | Feb 2024Led | $21 MOther Equity |
11 Items
11
Items
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 0 | 1 |
| Series A | 4 | 2 |
| Series B | 0 | 2 |
| Other Equity | 2 | 0 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Feb '24 | 1 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 1 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 1 |
| Dec '24 | 0 |
| Jan '25 | 1 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 1 |
| Oct '25 | 1 |
| Nov '25 | 1 |
| Dec '25 | 0 |
| Jan '26 | 1 |
| Feb '26 | 0 |
| Mar '26 | 1 |
| Apr '26 | 1 |
| May '26 | 1 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 10 |
| AI & Machine Learning | 6 |
| Enterprise Software | 3 |
| Networks, Cloud & Communication | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 0 |
| $10M-$25M | 6 |
| $25M-$50M | 3 |
| $50M-$100M | 0 |
| $100M-$250M | 2 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 1 of 1 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 11 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Flare Capital Partners | 3 |
| Frist Cressey Ventures | 2 |
| General Catalyst | 2 |
| Intermountain Ventures | 2 |
| Quiet Capital | 2 |
| SignalFire | 2 |
| Town Hall Ventures | 2 |
| 8VC | 1 |
| Accomplice | 1 |
| Allianz Life Ventures | 1 |
| Altos Ventures | 1 |
| Baszucki Group | 1 |
| Bling Capital | 1 |
| BlueCross BlueShield Venture Partners | 1 |
| Bon Secours Mercy Health | 1 |
| Cathay Innovation | 1 |
| Cedars-Sinai | 1 |
| CFO Advisors | 1 |
| Colle Capital | 1 |
| Convergent Ventures | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 6 | 55% |
| Participating | 5 | 45% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 4 | 67% |
| Co-led | 2 | 33% |
Team
Amir Dan Rubin
Chief Executive Officer